Teva Tries to Put an End to the Opioid Wars - WSJ
Teva announces $519 million FCPA settlement | The FCPA Blog
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva looks to amp up research collaborations, CEO says
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva's Richard Francis launches 'pivot to growth' strategy | Fox Business Video
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva plans massive layoffs; Overland Park office's future unclear - Kansas City Business Journal
Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
Teva profit plummets, stock slides | Ctech
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Teva Announces Launch of $2 Billion (Equivalent) Offering of Sustainability-Linked Senior Notes - ESG News
Layoffs To Deepen As Teva Unveils New Structure And Leadership Changes - Pharmaceutical Processing World
Here's Why Teva Pharma Stock Is Soaring Today
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva shares surge after announcing global opioid settlement
Clinics Across Florida, New Jersey & California Advancing Mental Health in Underserved Communities - Awarded Funding from Teva Pharmaceuticals, Direct Relief and NAFC | The National Association of Free & Charitable Clinics
Teva to pay New York $500M for role in opioid crisis - POLITICO
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Should You Sell Teva Pharmaceutical Industries Ltd (TEVA) Stock Friday Morning?
Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
Teva CEO stands down during troubled times - MedCity News
